Acquisition by Jeffrey Rhodes of tradable shares of Zimmer Biomet subject to Rule 16b-3
Zimmer Biomet Holdings Inc insider trading alert for grant of phantom stock units by Jeffrey Rhodes, the corporate stakeholder, on January 3, 2018. This event was filed by Zimmer Biomet Holdings In with SEC on 2018-01-03. Statement of changes in beneficial ownership - SEC Form 4
Filed transaction by Zimmer Biomet Holdings In director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
|This article from MacroaxisInsider published on 03 of January contributed to the next trading period closing price depreciation.The trading date delta to the next next day price was 0.14% . The trading date delta when the story was published to current price is 4.92% .|
Similar stores for Zimmer Biomet
See also Zimmer Biomet Hype Analysis, Zimmer Biomet Correlation and Zimmer Biomet Performance. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.